BiotechTube
Home/Stayble Therapeutics/Andreas Gerward
AG

Andreas Gerward

Chief Executive Officer

Stayble Therapeutics

Therapeutic Areas

Chronic PainMusculoskeletal Disorders

Stayble Therapeutics Pipeline

DrugIndicationPhase
STA363Chronic Low Back Pain due to Lumbar Disc Herniation (LDH)Phase 1b

Leadership Team at Stayble Therapeutics

SR
Sara Richardson
Former VP of CMC & Regulatory Affairs
View full Stayble Therapeutics profile